RE:Return to Glory DaysYup, that was quite a good quarter. I can only imagine how well the company will do once they get full access to health care professionals once again. Kudos to RX mgmt.
And, I think a dividend is going to happen eventually. Regular acquisitions in the pharma space have been too expensive for a very long time. Their method of getting the rights to products at a reasonable cost is working, so no need to change it.